Drug intelligence / Profile preview

Stillavit

Development stage
Unknown
Lead developer
Nizhpharm
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Stillavit is a multi-component ophthalmic solution used as a tear substitute and corneal protector. It contains three active ingredients: sodium hyaluronate, sodium chondroitin sulfate, and dexpanthenol (provitamin B5). The combination is designed to moisturize, protect, and promote the healing of the ocular surface by stabilizing the precorneal tear film and supporting epithelial regeneration. Sodium hyaluronate and chondroitin sulfate provide lubrication and structural support, while dexpanthenol promotes metabolic processes and tissue repair. In clinical practice, Stillavit is used to treat dry eye syndrome and as a preoperative preparation for ophthalmic surgeries, such as glaucoma filtration surgery, to improve surgical outcomes by reducing postoperative intraocular pressure elevation and filtering bleb scarring.

Brand names
Stillavit
Other names
Стиллавит
02

Targets

CD44 (CD44 antigen)PANK (Pantothenate kinase)

Beyond the preview

Go deeper on Stillavit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stillavit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call